IMRT-IGRT FOR BREAST CANCER IN ADJUVANT SETTING, OUR EXPERIENCE.

被引：0
|
作者：
San Jose, S. [1 ]
Manes, A. [1 ]
Calvo Ortega, J. F. [1 ]
Casals Farran, J. [1 ]
机构：
[1] Hosp Quiron Barcelona, Dept Radiat Oncol, Barcelona, Spain
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
649
引用
收藏
页码：S237 / S238
页数：2
相关论文
共 50 条
  • [31] Male breast cancer: Our experience
    Tozzi, L.
    D'Addetta, C.
    Latiano, T. P.
    Cafaro, A.
    El Jaouni, M.
    Piano, A.
    Murgo, R.
    Di Sebastiano, P.
    Parisi, S.
    Maiello, E.
    ANNALS OF ONCOLOGY, 2005, 16 : 14 - 14
  • [32] OUR EXPERIENCE OF BREAST-CANCER
    DEVIC, G
    GARDE, J
    GELAIN, J
    EYMARD, J
    LYON CHIRURGICAL, 1975, 71 (04) : 225 - 229
  • [33] Gemcitabine and docetaxel in metastatic breast cancer - further experience.
    Laufman, LR
    Spiridonidis, CH
    Boury, P
    Parker, T
    Glaub, E
    Maggard, V
    Miller, S
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S206 - S206
  • [34] Metaplastic breast cancer: A single-institution experience.
    Silva, Aumilto Augusto
    Linck, Rudinei Diogo Marques
    Lima, Julianne Maria da Silva
    Matutino, Adriana Reis Brandao
    Silva, Saulo Brito
    Vicentini, Maria Fernanda
    Felizola, Marcelo
    Gagliato, Debora De Melo
    Hoff, Paulo Marcelo
    Mano, Max S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [35] Sentinel node biopsy in breast cancer - The Cardiff experience.
    Clarke, D
    Khonji, N
    Daoud, R
    Sweetland, H
    Evans, W
    Rees, J
    Mansel, R
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (04): : S62 - S62
  • [36] Smoking increases breast toxicity despite adjuvant hypofractionated IMRT in early breast cancer
    Diaz-Gavela, Ana A.
    del Cerro, E.
    Sanchez-Garcia, S.
    Andreu-Vazquez, C.
    Thuissard-Vasallo, I. J.
    Sanz-Rosa, D.
    Pena-Huertas, M.
    Ruiz-Morales, C.
    Guerrero-Gomez, L. L.
    Duque-Santana, V.
    Hernandez-Cortes, G.
    Gonzalez-Cortijo, L.
    Counago, F.
    RADIATION ONCOLOGY, 2025, 20 (01)
  • [37] Breast cancer follow-up in the adjuvant setting
    James Khatcheressian
    Craig Swainey
    Current Oncology Reports, 2008, 10 : 38 - 46
  • [38] Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
    Lipton, Allan
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 122 (03) : 627 - 636
  • [39] Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
    Allan Lipton
    Breast Cancer Research and Treatment, 2010, 122 : 627 - 636
  • [40] The use of microarray analyses in the adjuvant setting for breast cancer
    不详
    EJC SUPPLEMENTS, 2004, 2 (09): : 100 - 100
12345